The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schoen Eric since 2011.
This trader's CIK number is 1532303.
At the time of last reporting, Schoen Eric was the Chief Financial Officer of Cassava Sciences Inc. (stock ticker symbol SAVA).
Also see all insider trading activities at Cassava Sciences Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | SAVA | 0 | $0 | 0 | $0 | 1,500 | $33,000 |
| 2022 | SAVA | 2,500 | $49,875 | 0 | $0 | 0 | $0 |
| 2020 | SAVA | 12,000 | $84,420 | 0 | $0 | 0 | $0 |
| 2019 | SAVA | 15,300 | $20,564 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | VRML | 3,347 | $4,685 | 0 | $0 | 0 | $0 |
| 2014 | VRML | 5,000 | $7,100 | 0 | $0 | 0 | $0 |
| 2011 | VRML | 19,525 | $23,039 | 0 | $0 | 0 | $0 |
1. Cassava Sciences Inc (SAVA)
2. Aspira Women's Health Inc. (VRML)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-04-17 | SAVA | Option Ex | 1,500 | 22.00 | 33,000 |
| 2022-08-12 | SAVA | Buy | 2,500 | 19.95 | 49,875 |
| 2020-09-17 | SAVA | Buy | 12,000 | 7.04 | 84,420 |
| 2019-12-19 | SAVA | Buy | 5,300 | 1.88 | 9,964 |
| 2019-05-14 | SAVA | Buy | 10,000 | 1.06 | 10,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-02-13 | VRML | Buy | 3,347 | 1.40 | 4,685 |
| 2014-11-18 | VRML | Buy | 5,000 | 1.42 | 7,100 |
| 2011-11-15 | VRML | Buy | 19,525 | 1.18 | 23,039 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schoen Eric (Chief Financial Officer of Cassava Sciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.